Journal
Clinical and Translational Medicine
Publication Date
2017
Volume
6
Inclusive Pages
11
Document Type
Open Access Publication
DOI
10.1186/s40169-017-0140-y
Rights and Permissions
Naoum GE, Zhu ZB, Buchsbaum DJ, Curiel DT, Arafat WO (2017) Survivin a radiogenetic promoter for glioblastoma viral gene therapy independently from CArG motifs. Clinical and Translational Medicine, 6:11. DOI: 10.1186/s40169-017-0140-y This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
Recommended Citation
Naoum, George E.; Zhu, Zeng B.; Buchsbaum, Donald J.; Curiel, David T.; and Arafat, Waleed O., "Survivin a radiogenetic promoter for glioblastoma viral gene therapy independently from CArG motifs." Clinical and Translational Medicine. 6, 11. (2017).
https://digitalcommons.wustl.edu/open_access_pubs/5733
